MEDIWELCOME HEALTHCARE MANAGEMENT & TECHNOLOGY INC
Associated tags: Health policy, Environment, Patient, Physician, Yoy, Non-governmental organization, Conference, Hospital, AI, Daou Technology Inc., Health insurance, Pharmaceutical industry, PRC
Mediwelcome Announced 2022 Interim Results
HONG KONG, Sept 23, 2022 - (ACN Newswire) - A China's leading provider of digital medical service solutions - Mediwelcome Healthcare Management & Technology Inc. ("Mediwelcome" or the "Company", and together with its subsidiaries, the "Group") (Stock Code: 2159), announced the unaudited consolidated interim results for the six months ended 30 June 2022 (the "Reporting Period" or the "First half of 2022").
- HONG KONG, Sept 23, 2022 - (ACN Newswire) - A China's leading provider of digital medical service solutions - Mediwelcome Healthcare Management & Technology Inc. ("Mediwelcome" or the "Company", and together with its subsidiaries, the "Group") (Stock Code: 2159), announced the unaudited consolidated interim results for the six months ended 30 June 2022 (the "Reporting Period" or the "First half of 2022").
- In the first half of 2022, Mediwelcome has narrowed in revenue and other aspects to varying degrees due to the continuous lockdown in many provinces in response to the severe pandemic in the PRC.
- In the first half of 2022, Mediwelcome's revenue decreased by approximately 49.2% to approximately RMB172.5 million YoY.
- To strengthen the Group's conference management capabilities, Mediwelcome has launched the Conference+ App for medical NGOs and pharmaceutical companies to submit onsite conference requests and monitor conference implementation.
Mediwelcome Announces 2021 Interim Results
HONG KONG, Aug 31, 2021 - (ACN Newswire) - The largest provider in the Integrated Healthcare Marketing Solutions Market of cardio-cerebral-vascular diseases (CCVDs), Mediwelcome Healthcare Management & Technology Inc. ("Mediwelcome" or the "Company", together with its subsidiaries, the "Group") is pleased to announce the unaudited consolidated interim results for the six months ended 30 June 2021 (the "Reporting Period" or the "First half of 2021").
- HONG KONG, Aug 31, 2021 - (ACN Newswire) - The largest provider in the Integrated Healthcare Marketing Solutions Market of cardio-cerebral-vascular diseases (CCVDs), Mediwelcome Healthcare Management & Technology Inc. ("Mediwelcome" or the "Company", together with its subsidiaries, the "Group") is pleased to announce the unaudited consolidated interim results for the six months ended 30 June 2021 (the "Reporting Period" or the "First half of 2021").
- In first half of 2021, the Group's revenue from CRO services increased by 40.1% YoY to RMB4.1 million.
- In the first half of 2021, the Group's internet hospital service revenue increased 25 times YoY to RMB 1.8 million.
- Mediwelcome established business partnerships with 5 domestic and foreign pharmaceutical companies in the first half of 2021.
Mediwelcome: Bringing High-Quality Medical Service Genes, or an Internet Hospital Upstart?
These resources can be migrated to the Internet hospital business, showing a unique advantage over a group of Internet medical technology giants.
- These resources can be migrated to the Internet hospital business, showing a unique advantage over a group of Internet medical technology giants.
- Therefore, the extension of Mediwelcome to the Internet medical service business is a matter of course.
- In November, the National Medical Security Administration officially listed its "Guiding Opinions on Actively Promoting "Internet +" Medical Services and Medical Insurance Payments" on its official website.
- Relying on the accumulation of original business, Mediwelcome can integrate doctor resources, professional knowledge, medical company resources and patient groups on the Internet hospital platform, thereby forming a complete Internet medical business closed loop.
Mediwelcome: Key Player in the Gold Track, is Forming a Head Leading Advantage
Mediwelcome: Key Player in the Gold Track, is Forming a Head Leading Advantage
Its Hong Kong shares (02159.HK) will list on January 19, so further exploration of the company's quality and reputation follows.
- Its Hong Kong shares (02159.HK) will list on January 19, so further exploration of the company's quality and reputation follows.
- In the long-term deep industrial cultivation process, Mediwelcome has formed a head leading advantage.
- As a head enterprise, Mediwelcome has a high probability of achieving continuous start by virtue of its leading edge.
- According to the prospectus, Mediwelcome has maintained long-term and stable business relations with world-renowned pharmaceutical companies and national medical organizations.
Mediwelcome: Reasonable valuation with HK listing on track for January 19
Its Hong Kong shares (02159.HK) will list on January 19, so further exploration of the company's quality and reputation follows.
- Its Hong Kong shares (02159.HK) will list on January 19, so further exploration of the company's quality and reputation follows.
- From the perspective of its long-term opportunities on the track, on the one hand, it is due to the improvement of industrial concentration.
- According to the prospectus, Mediwelcome has maintained long-term and stable business relations with world-renowned pharmaceutical companies and national medical organizations.
- Earlier, the market value of JD Health (06618.HK) briefly exceeded HK $600 billion, reflecting the market capital's pursuit of Internet medical treatment.